Bejelentkezés Regisztrálj ingyen

Inhibrx Quick ratio

Mi az Inhibrx Quick ratio?

A Quick ratio az Inhibrx, Inc. - 6.20

Mi a Quick ratio meghatározása?



A gyors arány a likviditási mutató, amely a vállalat azon képességét méri, hogy a gyors eszközeit azonnal felhasználhassa rövid távú kötelezettségeinek teljesítéséhez.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio a Health Care szektor a NASDAQ-on cégekben a Inhibrx -hoz képest

Mit csinál Inhibrx?

Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with locally advanced or metastatic solid tumors; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also provides INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company was founded in 2010 and is headquartered in La Jolla, California.

quick ratio -hoz hasonló cégek Inhibrx